Rita Z Goldstein1, Nora D Volkow. 1. Medical Research, Brookhaven National Laboratory, Bldg. 490, 30 Bell Avenue, Upton, NY 11973, USA. rgoldstein@bnl.gov
Abstract
OBJECTIVE: Studies of the neurobiological processes underlying drug addiction primarily have focused on limbic subcortical structures. Here the authors evaluated the role of frontal cortical structures in drug addiction. METHOD: An integrated model of drug addiction that encompasses intoxication, bingeing, withdrawal, and craving is proposed. This model and findings from neuroimaging studies on the behavioral, cognitive, and emotional processes that are at the core of drug addiction were used to analyze the involvement of frontal structures in drug addiction. RESULTS: The orbitofrontal cortex and the anterior cingulate gyrus, which are regions neuroanatomically connected with limbic structures, are the frontal cortical areas most frequently implicated in drug addiction. They are activated in addicted subjects during intoxication, craving, and bingeing, and they are deactivated during withdrawal. These regions are also involved in higher-order cognitive and motivational functions, such as the ability to track, update, and modulate the salience of a reinforcer as a function of context and expectation and the ability to control and inhibit prepotent responses. CONCLUSIONS: These results imply that addiction connotes cortically regulated cognitive and emotional processes, which result in the overvaluing of drug reinforcers, the undervaluing of alternative reinforcers, and deficits in inhibitory control for drug responses. These changes in addiction, which the authors call I-RISA (impaired response inhibition and salience attribution), expand the traditional concepts of drug dependence that emphasize limbic-regulated responses to pleasure and reward.
OBJECTIVE: Studies of the neurobiological processes underlying drug addiction primarily have focused on limbic subcortical structures. Here the authors evaluated the role of frontal cortical structures in drug addiction. METHOD: An integrated model of drug addiction that encompasses intoxication, bingeing, withdrawal, and craving is proposed. This model and findings from neuroimaging studies on the behavioral, cognitive, and emotional processes that are at the core of drug addiction were used to analyze the involvement of frontal structures in drug addiction. RESULTS: The orbitofrontal cortex and the anterior cingulate gyrus, which are regions neuroanatomically connected with limbic structures, are the frontal cortical areas most frequently implicated in drug addiction. They are activated in addicted subjects during intoxication, craving, and bingeing, and they are deactivated during withdrawal. These regions are also involved in higher-order cognitive and motivational functions, such as the ability to track, update, and modulate the salience of a reinforcer as a function of context and expectation and the ability to control and inhibit prepotent responses. CONCLUSIONS: These results imply that addiction connotes cortically regulated cognitive and emotional processes, which result in the overvaluing of drug reinforcers, the undervaluing of alternative reinforcers, and deficits in inhibitory control for drug responses. These changes in addiction, which the authors call I-RISA (impaired response inhibition and salience attribution), expand the traditional concepts of drug dependence that emphasize limbic-regulated responses to pleasure and reward.
Authors: P K Thanos; N D Volkow; P Freimuth; H Umegaki; H Ikari; G Roth; D K Ingram; R Hitzemann Journal: J Neurochem Date: 2001-09 Impact factor: 5.372
Authors: B E Wexler; C H Gottschalk; R K Fulbright; I Prohovnik; C M Lacadie; B J Rounsaville; J C Gore Journal: Am J Psychiatry Date: 2001-01 Impact factor: 18.112
Authors: H S Mayberg; M Liotti; S K Brannan; S McGinnis; R K Mahurin; P A Jerabek; J A Silva; J L Tekell; C C Martin; J L Lancaster; P T Fox Journal: Am J Psychiatry Date: 1999-05 Impact factor: 18.112
Authors: Rita Z Goldstein; Nora D Volkow; Linda Chang; Gene-Jack Wang; Joanna S Fowler; Richard A Depue; Ruben C Gur Journal: Neuroreport Date: 2002-12-03 Impact factor: 1.837
Authors: Hanbing Lu; Svetlana Chefer; Pradeep K Kurup; Karine Guillem; D Bruce Vaupel; Thomas J Ross; Anna Moore; Yihong Yang; Laura L Peoples; Elliot A Stein Journal: Neuroimage Date: 2012-06-01 Impact factor: 6.556
Authors: Martin Zack; Tracy M Woodford; Anne M Tremblay; Lindsay Steinberg; Laurie A Zawertailo; Usoa E Busto Journal: Neuropsychopharmacology Date: 2010-10-06 Impact factor: 7.853
Authors: Laura E Kwako; Melanie L Schwandt; Vijay A Ramchandani; Nancy Diazgranados; George F Koob; Nora D Volkow; Carlos Blanco; David Goldman Journal: Am J Psychiatry Date: 2019-01-04 Impact factor: 18.112
Authors: Jennifer L Stewart; Colm G Connolly; April C May; Susan F Tapert; Marc Wittmann; Martin P Paulus Journal: Addiction Date: 2013-12-15 Impact factor: 6.526
Authors: D Tomasi; R Z Goldstein; F Telang; T Maloney; N Alia-Klein; E C Caparelli; N D Volkow Journal: Brain Res Date: 2007-08-10 Impact factor: 3.252
Authors: Walter H Kaye; Christina E Wierenga; Ursula F Bailer; Alan N Simmons; Angela Wagner; Amanda Bischoff-Grethe Journal: Biol Psychiatry Date: 2013-02-04 Impact factor: 13.382